About Raregen
Raregen is a Financial Services company based in Durham (United States) founded in 2018, and was acquired by Liquidia in June 2020. Strategy planning and investment consulting are provided for healthcare sectors. It operates in the Financial Services and Healthcare sectors. Its chief executive, as recorded, is Roger Jeffs. Raregen offers products and services including YUTREPIA, L606, and PRINT Technology. Its focus areas include Services for Healthcare Providers, Consultancy Services and Services for Investment Industry. Its legal entity is Liquidia Corporation. Its competitors include Heartland Dental, Keplr Vision and The Chartis Group; 2 of its 3 listed competitors have raised funding.
Company details
Raregen was founded in 2018 and is headquartered in Durham, United States. Consulting services focused on strategy planning and investment are offered to clients in the healthcare sector. Operations emphasize advisory support for sector-specific challenges, including market analysis and financial guidance. Leadership is provided by CEO Roger Jeffs, with expertise centered on healthcare innovation and growth strategies.
- Headquarters Durham, United States
- Stage Acquired
- SectorsFinancial ServicesHealthcare
- Website raregenllc.com
- Social LinkedIn
- Acquired by Liquidia (Jun 2020)
- Legal Name Liquidia Corporation
Products & Services of Raregen
Raregen offers a comprehensive portfolio of products and services, including YUTREPIA, L606, and PRINT Technology.
Inhaled treatment for pulmonary arterial hypertension.
Drug candidate for pulmonary hypertension associated with lung disease.
Proprietary system for enhancing drug efficacy in cardiopulmonary care.
Investors in Raregen
Raregen has secured backing from 1 investor. Prominent investors backing the company include Liquidia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Engineered particles & films for life and material sciences applications | 2004 | liquidia.com | United States |
Investor details for Raregen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Raregen
52 people are tracked at Raregen (25 in leadership, 7 in board & advisors, 20 in team).
| Name | Role | Group |
|---|---|---|
Roger Jeffs | CEO | Leadership |
Dana B. | Chief Accounting Officer | Leadership |
Sean Y. | Senior Director, Commercial Ops & Analytics | Leadership |
Mike Kaseta | CFO | Leadership |
Rajeev Saggar | Chief Medical Officer | Leadership |
Sarah Krepp | Chief Human Resources Officer | Leadership |
Michael Hunter | Sr. Vice President, Manufacturing Operations | Leadership |
Mark Bailey | Regional Business Director - Northeast (rare Disease) | Leadership |
Frank L Bartolini | Senior Vice President Of Market Access | Leadership |
Matt Snow | Senior Vice President Of Sales | Leadership |
Marisa del Hierro | Sr. Director, Regulatory And PV Operations | Leadership |
Jason Adair | Chief Business Officer | Leadership |
Laura M. | Senior Director, Key Account Development | Leadership |
Jackie Morrison-Haddad | Regional Business Director, West Area | Leadership |
Derek Schorzman | Vice President, Manufacturing Sciences | Leadership |
Brandon Knez | Director Of Accounting | Leadership |
Gareth Gwyn | Vice President Medical Affairs | Leadership |
Jeff Kindig | Vice President, Quality | Leadership |
Michelle Gallant | Senior Director, U.s. Marketing | Leadership |
Scott Moomaw | Chief Commercial Officer | Leadership |
32 more people are available in the full profile.
Complete people profiles for Raregen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Raregen
2 dated milestones of Raregen across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Raregen is founded.
- Exit Acquired by Liquidia.
Competitors of Raregen
Raregen has 3 listed competitors in our database, 2 of them funded. They include Heartland Dental, Keplr Vision and The Chartis Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| heartland.com | 1997 | Effingham, United States | $1.57M | 13,998 | Provider of healthcare consulting services | |
| keplrvision.com | 2019 | Bloomington, United States | $80M | Business support and supply chain management services are offered. | ||
| chartis.com | 2001 | Chicago, United States | 495 | Advisory services are offered to U.S. healthcare providers. |
Detailed competitors of Raregen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Investment & Wealth Tech
3 companies that operate in the same segment as Raregen (Investment & Wealth Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cloud-based website builder tool | 2003 | New York, New York, United States | USD 591.5 M | USD 16.79 M | 2,161 | |
Alternative investment platform for startups and investors is operated. | 2010 | San Francisco, California, United States | USD 100 M | 523 | ||
Web3 infrastructure solutions are offered via a blockchain platform. | 2021 | Palo Alto, California, United States | USD 336 M | 186 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Raregen
Complete news archive for Raregen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raregen
Raregen was founded in 2018.
Raregen is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Roger Jeffs is the CEO of Raregen, as recorded in our data.
Raregen was founded in 2018 and is headquartered in Durham, United States. Consulting services focused on strategy planning and investment are offered to clients in the healthcare sector. Operations emphasize advisory support for sector-specific challenges, including market analysis and financial guidance. Leadership is provided by CEO Roger Jeffs, with expertise centered on healthcare innovation and growth strategies.
Raregen's top competitors include Heartland Dental, The Chartis Group and Keplr Vision.
Raregen offers YUTREPIA, L606, and PRINT Technology.
Raregen has 1 investor. Key investors include Liquidia.
Raregen operates through Liquidia Corporation.
Yes. Raregen was acquired by Liquidia in June 2020.